chrisvoncsefalvay/vaers-outcomes huggingface dataset:
BUTTOCK CHEEKS AND ANAL AREA FEELS LIKE BURNING SENSATION; BUTTOCK CHEEKS AND ANAL FEELS IRRITATED; BUTTOCK RASH; This spontaneous report received from a patient concerned a 64 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: penicillin allergy, and other pre-existing medical conditions included: Patient had no other symptoms/complaints after receiving vaccine. Patient's family doctor did not see any rash or any blood in stool and redness. The patient experienced drug allergy when treated with codeine for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-SEP-2021, the patient experienced buttock rash. On 15-SEP-2021, the patient experienced buttock cheeks and anal area feels like burning sensation. On 15-SEP-2021, the patient experienced buttock cheeks and anal feels irritated. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from buttock rash, and the outcome of buttock cheeks and anal area feels like burning sensation and buttock cheeks and anal feels irritated was not reported. This report was non-serious.
hive marks in back area; Round and raise marks/ had 8 to 9 large marks ½ inch wide/ 2 or 3 large marks at least 2 inches wide; marks were stinging; This case was reported by a consumer via call center representative and described the occurrence of hives in a 20-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number G05NG, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced hives, raised rash and stinging. On an unknown date, the outcome of the hives, raised rash and stinging were unknown.   It was unknown if the reporter considered the hives, raised rash and stinging to be related to Boostrix.  Additional details were provided as follows: The case was reported by patient's parent. The age at vaccination was not reported. The patient received Boostrix vaccine in the right arm and experienced few hive marks in the back area, the marks were round and raise the patient had 8 to 9 large marks ½ inch wide and the marks were stinging. The reporter did not consent to follow up
Fully vaccinated and hospitalized.  The patient's daughter reported that she experienced a: Fever, Abdominal Pains, Cough and a runny nose. Symptoms started on 8/6. The patient's daughter stated that she lives with her and her fiance who both tested positive. Reported current smoker and Diabetes as pre-existing medical conditions.
It was reported that a 44 year old white male was vaccinated in 1995 with a dose of pneumococcal vaccine 23 polyvalent and a dose of influenza virus vaccine. At the time of vaccination, the pt's CD4 count was 250 cells/microL (19%) and he was prescribed concomitantly zidovudine, lamivudine and sulfamethoxazole/trimethoprim. It was noted that over the subsequent 2 years, there was a transient increase of his CD4 count to a maximum of 370 cells/microL and then a slow decline. The pt presented in 4/97 to the ER with a 6 day history of violent shaking chills, night sweat and malaise. The pt reported shortness of breath, occasional blood-tinged sputum and pleuritic chest pain for 3 days. The pt was known to have been HIV (+) for 8 years, with risk factors including IV drug abuse. It was noted that the pt had received medical care at the infectious disease clinic at the same hospital. It was noted that at his last appointment, 3 months prior to his presentation to the ER, the pt had a CD4 cell count of 216 cells/microL (16%) and his viral load was 1270 copies/mL. It was reported that the pt completely recovered from a hepatitis b infection, but hat a history of chronic sinusitis and hepatitis C. The pt had never suffered from the opportunistic infections common in AIDS. It was reported that in the ER, the pt was poorly cooperative, appeared pale and coughed occasionally. He was afebrile, hypoxemic and had oliguria. Septic shock with severe bacterial pneumonia was dx'd. Ceftazidime, erythromycin, sulfamethoxazole/trimethoprim and IV hydration were administered. It was reported that the pt required orotracheal intubation and mechanical ventilation. About 11 hours after presenting to the ER, the pt developed recurrent ventricular tachycardia and expired. It was noted that with the exception of minimal aseptic leptomeningitis, the neuropathological findings were unremarkable. There was no evidence that the pt had a concurrent influenza infection. It was reported that Streptococcus pneumoniae was cultured from various blood samples. The organism was sensitive to penicillin, chloramphenicol, vancomycin and erythromycin. It was noted that the pneumococcal vaccine 23 polyvalent included isotype 3.
Muscle soreness around injection site; This is a spontaneous report from a non-contactable consumer (patient). A 39-years-old female patient received bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6200, Expiration date was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 22Feb2021 at 06:00 PM as 1st dose, single for covid-19 immunisation. The patient medical history was not reported. Concomitant medication included lamotrigine (LAMOTRIGINE). The patient was not pregnant at the time of vaccination. Patient had no other vaccine in last four weeks. Patient was not tested COVID prior and post vaccination. On 22Feb2021 at 08:30 PM, the patient experienced muscle soreness around injection site. The outcome of event was recovering.  No follow up attempts are possible. No further information is expected.
Pt vaccinated with DTP/OPV developed angioedema within 24 hrs after DTP/OPV given resolved within 48 hrs.
The morning after my vaccine I got very nauseous and bad body aches which required me to leave work at lunch time to come home. Since then, the nausea has resolved but I still continue to have body aches, weakness and fatigue. I also have a rash on my right arm ~2 in below the vaccine injection site. It is hot and tender to touch. And very red.
Area red, swollen (lt. thigh) - Pt's mother states "was running fever" but did not take Pt's temperature.
Felt achy; puffy/dry eyes that felt like I'd been swimming in a chlorinated pool; puffy/dry eyes that felt like I'd been swimming in a chlorinated pool; headache; This is a spontaneous report from a contactable consumer (patient).  A 62-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0170) on 19Apr2021 at 13:45 (age at the time of vaccination was 62-year-old) as dose 2, single and first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: FR8732) on 29Mar2021 at 13:45 as dose 1, single both via an unspecified route of administration, administered in left arm for COVID-19 immunisation. The patient's medical history included hypothyroidism from an unknown date and unknown if ongoing (generally good health). Concomitant medications included levothyroxine sodium (LEVOTHYROXIN), 100 mg, daily, taken for an unspecified indication with no start and stop dates reported. On 20Apr2021 at 12:00 patient felt achy, she had puffy/dry eyes that felt like i'd been swimming in a chlorinated pool and headache. It was reported that patient had puffy/dry eyes that felt like I'd been swimming in a chlorinated pool after 24 hours of vaccine which lasted another day or two (maybe longer?). Patient also had a headache that second day, which she did not get, normally. Additionally, patient felt achy and went to bed early that second day. The patient was not pregnant at the time of vaccination. There were no known allergies reported. She had been taking 100 mg Levothyroxin daily within two weeks of vaccination. There were no other vaccines administered in four weeks. She had not been diagnosed with COVID-19 prior to vaccination and tested since the vaccination. Patient had not received any treatment as a result of events. The outcome of events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Apneic, cyanotic episode the evening of the vaccines (6-8 hrs after vaccine). Tactile stimulation was the only intervention 911 called. Exam only showed temp of 100.8 (R) otherwise well by the time of exam.
Information has been received from a health professional concerning a 9 year old male with a history of asthma and rhinitis allergies who on 22-JAN-1999 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On 12-OCT-2007, the patient developed a varicella rash. There was not illness at the time of vaccination. There was no relevant diagnostic tests and laboratory data. Unspecified medical attention was sought. On 19-OCT-2007, the outcome was reported as recovered. There was no product quality complaint. Additional information has been requested.
Onset of hip and low back pain day 5 that progressed to nerve pain in R thigh along L2/3 distribution. On day 13 following vaccine, shingles rash developed in low back and R groin in L2/3 distribution. Currently on Valtrex and Gabapentin.
Swelling in face and hands starting about 6-8 hrs after vaccine. Body aches, swelling in knees as well. Nausea and some symptoms persisted for a week, including insomnia on 6/1/15, given Prednisone 20mg BID X 5 days; Improved (Pain (L) arm and jaw, palpitations as well).
Breakthrough case after three vaccines Moderna 2/24/21 Lot# 007M20A;  Moderna 3/24/21 Lot# 011M20A;  Moderna 12/10/21 Lot# 012H21B
Headache that worsened and turned into a migraine without relief from Tylenol, Benadryl, and Fioicet
arm was sore 6-7 days; shaking about half hour / whole body shaking; crying uncontrollably; weak / laid low; This case was reported by a consumer via other manufacturer and described the occurrence of pain in arm in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2020, the patient received the 1st dose of Shingrix. In September 2020, less than 6 months after receiving Shingrix, the patient experienced pain in arm, tremor, crying uncontrollable and weakness. On an unknown date, the outcome of the pain in arm, tremor, crying uncontrollable and weakness were unknown.   It was unknown if the reporter considered the pain in arm, tremor, crying uncontrollable and weakness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 1st dose of shingrix at 5:00 pm and experienced pain in arm,tremor,crying uncontrollable and weak. The patient was scheduled to get covid vaccine with an hour but not sure whether vaccinated or not. The information regarding consent to follow was not reported.
no additional AE; inadvertent administration via intramuscular route; This spontaneous report was received from a registered nurse and refers to a 5-year-old male patient. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 22-SEP-2021, the patient was vaccinated with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant Human albumin (rHA)) (PROQUAD) lot# T035411 has been verified to be a valid lot number, expiration date 14-APR-2022, 0.5 milliliter, inadvertently administered intramuscularly as opposed to the recommended subcutaneous route (incorrect route of product administration) (formulation, and anatomical location were not reported) for prophylaxis. No other adverse event was reported.
COVID Positivity on Antigen Test; COVID Positivity on Antigen Test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 48 years for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "recovering" and all described as "COVID Positivity on Antigen Test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of COVID-19. Clinical course: Patient had not COVID-19 prior vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Large brusing on left arm. Bruising through out body.  All brusing appeared 2 weeks after vaccination
Left arm became sore at area of injection around noon. At 14:50, arm was swollen and red and hot to touch. Taken to MD and dx'd with allergy to TD. Treated with Claridin and Certex.
Information has been received from a physician referring to a 24 year old female patient. No pertinent or historical conditions were reported. On 23-OCT-2015, the patient was inadvertently administered with a dose of VARIVAX (Merck) (lot # L025205, 07-JUL-2017, strength, dose and indication unknown). At the time of vaccination, the patient was pregnant (currently 9 weeks and 2 days gestation) with Last Menstrual Period (LMP) of 19-AUG-2015 and Estimated Date of Delivery (EDD) of 26-MAY-2016. No adverse effects were reported. Additional information has been requested.
6.5x7.5 cm area of erythema & heat & soreness lt deltoid area; no induration or swelling;
Itching on stomach; Rash on stomach and back of neck; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching on stomach) and RASH (Rash on stomach and back of neck) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced PRURITUS (Itching on stomach) and RASH (Rash on stomach and back of neck). At the time of the report, PRURITUS (Itching on stomach) and RASH (Rash on stomach and back of neck) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported. No treatment information after the first dose was provided. Action taken with mRNA-123 is not applicable.   This case was linked to MOD-2021-066174, MOD-2021-066174 (Patient Link).
pt recvd vax & devel t; was fussy, irritable, v; next am pt color changed & cried out & became stiff w/ eyes rolled back; then remained flaccid & floppy w/ questionable breathing; cpr performed by parent; to er; admitted for observation;
Had fatigue, headache, muscle aches, chills , and nausea from 01/08/2021 to 01/10/2021 to where I could not perform daily functions.
Urticarial rash on trunk, legs, extremities, itchy. Parent sent us pictures which were consistent with urticaria.
This case was reported in a literature article and described the occurrence of uveitis in a 11-year-old male subject who was vaccinated with Hepatitis B vaccine (manufacturer unspecified). On an unspecified date the subject received 1st dose of Hepatitis B vaccine (unknown). One day after vaccination with Hepatitis B vaccine, the subject experienced uveitis, optic neuritis and retinitis. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after Hepatitis B vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complex deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Approx. 8 hours following  injection, on Friday, 2/5 at 3:45 p.m., began experiencing  the following symptoms: low grade fever (99.1 F); Left arm numbness and pain from deltoid to fingers; severe joint pain in L thumb, Index, and middle fingers; headache; chills; systemic muscular weakness; dizziness/nausea; extreme fatigue.  Symptoms began to abate on Sunday 2/7 at approx. 8 p.m., and had completely abated by Monday 2/8 at 6 a.m.
Noticeable sting immediately during injection (11:30am) Felt like a wasp sting, then faded away after about 60 seconds.   Left arm hurt in area of the injection site. Felt sore and painful to the touch.  Felt like as of someone punched me in the arm.   Woke up the next morning around 6am. Arm is still sore, but is now sore in an area away from injection sore. Soreness, rash, and pain about half way down the arm. Looks to be about 3 inches across by 2 inches in height. (Rectangular shape). Slightly raised, and warm to the touch.   Currently 6:30pm, day after moderna shot. All reactions are still on my arm.   Other noticeable  side effects include sore neck, upper back, and shoulder muscles. Feels right, and has a persistent sore feeling, as if I worked out my upper body. I have been resting most of that day today and yesterday as well.
Diarrhea, fever progressing to 101.8 Fahrenheit, chills, weakness
SX: hot and cold body temperature variation. moderate dizziness. alternating temporal / frontal headache and nausea.  strange feeling overall.   TX: Extra resting/observation time provided by medical staff following injection.  TIME PERIOD: remained at vaccination clinic area for 30 minutes.  Returned to work clinic following injection, symptoms remaining but milder.  By 10:15, all symptoms dissipating, but fatigue setting in.  Feeling uncoordinated, foggy thinking, difficulty with concentration.  Mild headache becoming some consistent.
Went for blood work 2 days after receiving Pfizer covid vaccine and had low white cell counts
Information has been received from the father of a 15 month old male who was vaccinated with MMR II and immediately, post vax, the pt experienced signs of autism. Upon internal review, autism was considered an "Important Medical Event". No further information is available.  Follow up on 03/28/2001: "Patient date of birth, adverse onset date and time, Lot # for vaccine 1 and vaccine administration date/time is not provided."
Mom called H.D. stated temp 102 on 8FEB91; Mom states child has "bad cold"
burning pain in the distribution of the left facial nerve, loss of taste, hyperacusis left ear
pt recv vax 30JUN97 & @ an unspecified time p/vax pt reported urticaria that spread from arm to leg, to the other arm & to the face sequentially;there was no diff breathing or other sx reported;
On 14APR2014, information was received from a consumer on behalf of his brother. The reporter stated that his brother had received the Anthrax vaccine (date, dose, lot# not reported). On an unspecified date the male was diagnosed with Crohn's disease. At the time of report, the Crohn's disease was in remission. The reporter stated that there was no prior family history of Crohn's disease. Reporter stated that the subject is in remission. Follow-up information has been requested.
Information has been received from a physician concerning a nine year old female patient with no pertinent medical history who on 1/23/97 was vaccinated with a dose of varicella virus vaccine live (lot # 620630/1345D). There was no concomitant medication. On 5/3/04, the patient was diagnosed with a mild case of chicken pox. She had no fever and no treatment was required. The patient has recovered. There was no product quality complaint reported. Additional information has been requested. The physician also mentioned another female patient who experienced a similar reaction following vaccination with varicella virus vaccine live (lot # 646360/0571N) (WAES0408USA01180).
Pt was recieving injections for a trip. Needed 5 vaccines all together. Just as the last one was given she stated she did not feel well and slumped in her chair, with tonic- clonic movements for about 30 seconds. When pt awoke she seemed to be oriented x3 and was taken to the Emergency Department for further evaluation. Vital signs were BP, 104/52, P, 52 Blood Glucose level, 162
Freezer that vaccine was stored in was turned off and temperature was not being monitored until after the vaccine was administered.
Case fully vaccinated with Moderna with second dose administered on 2/12/21. Tested positive for COVID 19 on 9/15/2021. Admitted to Medical Center on 9/14/2021. Case expired on 9/27/2021 while still hospitalized.
Pt recieved flu shot in ER where she works as AD ER RN.  She developed rapid onset of globus, chest and throat tightness and tachypnea.  ER MD assessed patient as having anaphylactic reaction and administered Epi 0.5mg IM x3, Duoneb x4, O2, Benedryl, Zantac, Visteril and called Allergy (me) after 45min.  Patient seen by me with pallor and rapid breathing.  Started to scratch and noted excoriations and mild dematographism but no hives.  No hypoxia but ER clinical impression was that of impressive reaction.  Requested tryptase and histamine be drawn and pending.  Pt admitted for observation and will f/u with me for further recommendations.
Patient reports approximately 15 hours after receiving vaccines, experienced abdominal cramping, became very pale, felt cold and sweaty, and vomited once.  After vomiting, states she felt better, but still felt cold.  Patient also says she is due for her menses.
Fatigue; shortness of breath when walking or talking; fast heartbeat; passed out twice (the second time I passed out on the floor, lost  consciousness for a few seconds and hit my face and  my nose on the floor.   My left calf hurts as well.